Synthesis and biological evaluation of a series of novel pyridinecarboxamides as potential multi-receptor antipsychotic drugs

https://doi.org/10.1016/j.bmcl.2018.01.038Get rights and content

Abstract

In previous study, a series of benzamides was identified as potent antipsychotic agents. As a continuation of the program to discover novel antipsychotics, herein we reported the evaluation of a series of pyridinecarboxamide derivatives. The most promising compound 7h not only held good activities on dopamine D2, serotonin 5-HT1A and 5-HT2A receptors, but also exhibited low potency for α1A, H1 and 5-HT2C receptors, indicating a low propensity of side effects like orthostatic hypotension and weight gain. Furthermore, 7h exhibited more potent antipsychotic-like effect than aripiprazole in behavioral studies. The preliminary results were promising enough for further research around this scaffold.

Section snippets

Acknowledgements

This work was supported by Special Fund for Strategic Pilot Technology of Chinese Academy of Sciences (Grant No. XDA12040208).

References (23)

  • W. Rossler et al.

    Eur Neuropsychopharmacol

    (2005)
  • S.R. Marder et al.

    Schizophr Res

    (1991)
  • E.H.F. Wong et al.

    Pharmacol Ther

    (2010)
  • H.Y. Meltzer et al.

    Prog Neuro-Psychopharmacol Biol Psychiatry

    (2003)
  • H.Y. Meltzer et al.

    Curr Opin Pharmacol

    (2011)
  • J. Savitz et al.

    Prog Neurobiol

    (2009)
  • E. Akimova et al.

    Biol Psychiatry

    (2009)
  • F. Yang et al.

    Bioorg Med Chem Lett

    (2016)
  • J.Y.T. Leung et al.

    Pharmacol Ther

    (2012)
  • B.J. Morris et al.

    Curr Opin Pharmacol

    (2005)
  • D.R. Weinberger et al.

    Schizophrenia

    (2011)
  • Cited by (6)

    • Green chemistry and synthetic approaches in the development of antidepressant and antipsychotic agents

      2020, Green Approaches in Medicinal Chemistry for Sustainable Drug Design
    View full text